Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-CPS-001, which is in a Phase 1 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-SYNGAP for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/08/2025 07:12 PDT] CAMP Expected to Trade Up After Bullish Patterns Develop
• [04/22/2025 07:26 PDT] CAMP Expected to Trade Up After Bullish Patterns Develop
• [04/08/2025 16:11 PDT] CAMP4 THERAPEUTICS CORPORATION (NASDAQ:CAMP), Down By 100% ($3.03) From $3.03 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [04/08/2025 16:11 PDT] CAMP4 THERAPEUTICS CORPORATION (NASDAQ:CAMP), Down By 100% ($3.09) From $3.09 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [04/07/2025 08:02 PDT] CAMP Expected to Trade Down After Bearish Patterns Develop
• [04/04/2025 07:38 PDT] CAMP Expected to Trade Down After Bearish Patterns Develop
• [03/25/2025 11:45 PDT] CAMP SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [03/11/2025 16:11 PDT] CAMP SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.